Bionano Genomics Inc — Quarterly Financial Statistics (NASDAQ:BNGO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -6.5 M-2.76 M-3.49 M-5.92 M-4.17 M -16.34 M Cash from investing activities 3 M-14.07 M1.98 M-4.67 M4.01 M -12.75 M Cash from financing activities 3.89 M10.89 M1.47 M10.08 M1.6 M 24.04 M Free cash flow -6.5 M-2.76 M-3.49 M-5.92 M-4.17 M -16.34 M

News

Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call Transcript

Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Bionano Genomics (NASDAQ:BNGO)

Bionano study shows optical genome mapping detects gene editing alterations

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

H.C. Wainwright reiterates Buy rating on Bionano Genomics stock with $7 target

Bionano Genomics stock price target lowered to $7 at H.C. Wainwright

Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday - Barrick Mining (NYSE:B), Baidu (NASDAQ:BIDU)

Bionano Genomics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:BNGO) 2025-11-14

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Bionano Genomics Q3 2025 slides: 21% revenue growth amid cost structure improvements

iBio, Inc. (IBIO) Reports Q1 Loss

Bionano study shows optical genome mapping enhances leukemia detection